Christopher M. Holman

559 total citations
100 papers, 317 citations indexed

About

Christopher M. Holman is a scholar working on Management of Technology and Innovation, Physiology and Artificial Intelligence. According to data from OpenAlex, Christopher M. Holman has authored 100 papers receiving a total of 317 indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Management of Technology and Innovation, 32 papers in Physiology and 21 papers in Artificial Intelligence. Recurrent topics in Christopher M. Holman's work include Intellectual Property and Patents (37 papers), Biomedical Ethics and Regulation (32 papers) and Law, AI, and Intellectual Property (21 papers). Christopher M. Holman is often cited by papers focused on Intellectual Property and Patents (37 papers), Biomedical Ethics and Regulation (32 papers) and Law, AI, and Intellectual Property (21 papers). Christopher M. Holman collaborates with scholars based in United States, Singapore and Canada. Christopher M. Holman's co-authors include Harold E. Van Wart, William F. Benisek, Chen‐Chen Kan, Michelle F. Browner, Anthony Welch, Michael R. Gehring, Mitchell C. Brenner, Martin Huber, S. Sean Tu and Robert Cook‐Deegan and has published in prestigious journals such as Science, Nature Biotechnology and Biochemistry.

In The Last Decade

Christopher M. Holman

68 papers receiving 282 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher M. Holman United States 9 125 83 67 58 48 100 317
Andreï Mogoutov France 9 52 0.4× 43 0.5× 13 0.2× 14 0.2× 64 1.3× 15 374
Neha Tripathi India 11 146 1.2× 16 0.2× 23 0.3× 107 1.8× 8 0.2× 45 393
Rongzhi Liu China 12 220 1.8× 19 0.2× 58 0.9× 100 1.7× 14 0.3× 32 701
Laura M. McNamee United States 10 132 1.1× 30 0.4× 11 0.2× 41 0.7× 118 2.5× 13 361
Jeff Johnson United States 13 261 2.1× 18 0.2× 54 0.8× 158 2.7× 10 0.2× 28 715
Sabarni K. Chatterjee United States 11 335 2.7× 23 0.3× 78 1.2× 171 2.9× 87 1.8× 11 642
Masako Ueda United States 16 83 0.7× 164 2.0× 51 0.8× 19 0.3× 325 6.8× 52 1.1k
Sang-Chul Park South Korea 11 128 1.0× 19 0.2× 19 0.3× 95 1.6× 18 0.4× 48 431
Qianyi Sun China 7 145 1.2× 13 0.2× 97 1.4× 36 0.6× 72 1.5× 15 455
Junping Yang China 12 127 1.0× 32 0.4× 76 1.1× 47 0.8× 5 0.1× 47 357

Countries citing papers authored by Christopher M. Holman

Since Specialization
Citations

This map shows the geographic impact of Christopher M. Holman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher M. Holman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher M. Holman more than expected).

Fields of papers citing papers by Christopher M. Holman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher M. Holman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher M. Holman. The network helps show where Christopher M. Holman may publish in the future.

Co-authorship network of co-authors of Christopher M. Holman

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher M. Holman. A scholar is included among the top collaborators of Christopher M. Holman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher M. Holman. Christopher M. Holman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Holman, Christopher M.. (2023). A 2023 Review of Legislation Aimed at Increasing Generic and Biosimilar Competition. Biotechnology Law Report. 42(2). 68–83.
2.
3.
Holman, Christopher M.. (2022). Univ. of Massachusetts v. L'Oreal S.A.. Biotechnology Law Report. 41(4). 212–218. 1 indexed citations
4.
Holman, Christopher M.. (2022). AstraZeneca AB v. Mylan Pharms. Inc.. Biotechnology Law Report. 41(2). 93–105. 1 indexed citations
5.
Holman, Christopher M.. (2022). Is the Chemical Genus Claim Really “Dead” at the Federal Circuit?: Part I. Biotechnology Law Report. 41(1). 4–22.
6.
Holman, Christopher M.. (2022). Is the Chemical Genus Claim Really “Dead” at the Federal Circuit?: Part II. Biotechnology Law Report. 41(2). 58–77. 1 indexed citations
7.
Holman, Christopher M.. (2021). In Juno v. Kite the Federal Circuit Strikes Down Patent Directed Towards Pioneering Innovation in CAR T-Cell Therapy. Biotechnology Law Report. 40(6). 372–388. 3 indexed citations
8.
Holman, Christopher M.. (2021). Government Involvement in Pharmaceutical Development Can Come Back to Haunt a Drug Company. Biotechnology Law Report. 40(1). 4–20.
9.
Holman, Christopher M.. (2020). Ajinomoto v. ITC , the Doctrine of Equivalents, and Biomolecule Claim Limitations at the Federal Circuit. Biotechnology Law Report. 39(1). 3–18.
10.
Holman, Christopher M.. (2020). Inherency in the Patenting of Biotechnology and Pharmaceutical Innovation. Biotechnology Law Report. 39(2). 79–99.
11.
Holman, Christopher M.. (2020). Patent Term Adjustment: Recent Developments at the Federal Circuit and PTO. Biotechnology Law Report. 39(4). 266–278. 1 indexed citations
12.
Holman, Christopher M.. (2019). Gilead Sciences Sued for Failing to Bring a Follow-On Version of Truvada to Market Sooner. Biotechnology Law Report. 38(5). 267–275. 2 indexed citations
13.
Holman, Christopher M.. (2019). Congress Considering Legislation Aimed at Increasing Competition in Pharmaceuticals. Biotechnology Law Report. 38(3). 144–153. 2 indexed citations
14.
Holman, Christopher M.. (2019). A Fractured International Response to CRISPR-Enabled Gene Editing of Agricultural Products. Biotechnology Law Report. 38(1). 3–23. 7 indexed citations
15.
Holman, Christopher M.. (2017). The Supreme Court's Devaluation of U.S. Patents. Biotechnology Law Report. 36(4). 151–166. 2 indexed citations
16.
Holman, Christopher M.. (2016). Setbacks in Implementing the Renewable Fuel Standard Lead to Calls for Reform. Biotechnology Law Report. 35(6). 249–257. 1 indexed citations
17.
Holman, Christopher M., et al.. (2016). Are Engineered Genetic Sequences Copyrightable?: The U.S. Copyright Office Addresses a Matter of First Impression. Biotechnology Law Report. 35(3). 103–111. 3 indexed citations
18.
Holman, Christopher M.. (2016). Trade Secret Law: An Increasingly Important Form of IP for Biotechnology. Biotechnology Law Report. 35(2). 45–54. 1 indexed citations
19.
Holman, Christopher M.. (2015). Status Update: Implementation of the Patent Dispute Resolution Provisions of the Biologics Price Competition and Innovation Act. Biotechnology Law Report. 34(6). 247–251. 1 indexed citations
20.
Holman, Christopher M.. (2014). Caught Between a Rock and a Hard Place: How Limelight Compounds the Challenges Facing Biotechnology Innovators After Mayo and Myriad. Biotechnology Law Report. 33(4). 135–138. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andreï Mogoutov Breakdown of academic impact, for papers by Neha Tripathi Breakdown of academic impact, for papers by Rongzhi Liu Breakdown of academic impact, for papers by Laura M. McNamee Breakdown of academic impact, for papers by Jeff Johnson Breakdown of academic impact, for papers by Sabarni K. Chatterjee Breakdown of academic impact, for papers by Masako Ueda Breakdown of academic impact, for papers by Sang-Chul Park Breakdown of academic impact, for papers by Qianyi Sun Breakdown of academic impact, for papers by Junping Yang
Rankless by CCL
2026